0001127602-25-019220.txt : 20250715 0001127602-25-019220.hdr.sgml : 20250715 20250715171845 ACCESSION NUMBER: 0001127602-25-019220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250714 FILED AS OF DATE: 20250715 DATE AS OF CHANGE: 20250715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEE STEVEN HYOSIG CENTRAL INDEX KEY: 0001855708 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 251125656 MAIL ADDRESS: STREET 1: 160 SOUTH INDUSTRIAL BLVD CITY: CALHOUN STATE: GA ZIP: 30701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2025-07-14 0000885590 Bausch Health Companies Inc. BHC 0001855708 LEE STEVEN HYOSIG 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807 1 SVP, Controller & CAO 0 Common Shares, No Par Value 2025-07-14 4 A 0 27371 0 A 27371 D Represents the award of restricted share units ("RSU s") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. /s/ Brianna M. Cetrulo, attorney-in-fact 2025-07-15